TRCT
ADGM

Tower Research Capital (TRC)’s Adagio Medical Holdings ADGM Stock Holding History

Tower Research Capital (TRC)’s Portfolio ADGM Stock Details ADGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.21K Buy
6,454
+4,252
+193% +$4.16K ﹤0.01% 4422
2026
Q1 		$2.53K Sell
2,202
-5,944
-73% -$6.03K ﹤0.01% 4462
2025
Q4 		$8.47K Buy
8,146
+6,062
+291% +$7.19K ﹤0.01% 3946
2025
Q3 		$4.04K Sell
2,084
-1,390
-40% -$2.16K ﹤0.01% 4412
2025
Q2 		$4.52K Buy
3,474
+804
+30% +$916 ﹤0.01% 4315
2025
Q1 		$2.15K Sell
2,670
-1,784
-40% -$1.89K ﹤0.01% 4582
2024
Q4 		$4.68K Buy
4,454
+3,694
+486% +$8.92K ﹤0.01% 4416
2024
Q3 		$1.96K Buy
+760
New +$3.62K ﹤0.01% 5069

Other funds holding ADGM

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tower Research Capital (TRC)'s ADGM Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Adagio Medical Holdings (ADGM) stake by 193% in Q2 2026, buying an estimated $4.16K and bringing the position to 6,454 shares worth $4.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4422.

Tower Research Capital (TRC) first reported a position in ADGM in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.47K in Q4 2025. 24 funds tracked by Wall St. Rank hold ADGM as of Q2 2026.

  • Tower Research Capital (TRC) held 6,454 shares of Adagio Medical Holdings worth $4.21K as of Q2 2026.
  • Tower Research Capital (TRC) bought 4,252 Adagio Medical Holdings shares in Q2 2026, an estimated $4.16K.
  • Adagio Medical Holdings made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4422 holding.
  • Tower Research Capital (TRC) first reported a position in Adagio Medical Holdings in Q3 2024 and has held it in 8 quarters since.
  • Tower Research Capital (TRC)'s Adagio Medical Holdings position peaked at $8.47K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Adagio Medical Holdings as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.